Jones has signed with Verve for representation. She continues to be repped by Mosaic and Jackoway Austen Tyerman.

EXCLUSIVE: Emmy-nominated filmmaker and actress Sonja O’Hara has signed on to direct the feature project Cottagecore, which ...

GOAL US writers discuss PSG's absolutely mauling of Inter in the Champions League final, and whether it was good for the game ...

Verve Therapeutics, Inc., a clinical-stage company, develops gene editing medicines for patients to treat cardiovascular disease in the United States. The company’s product candidates include ...

Tal Schneider is a Political Correspondent at The Times of Israel May 22, 2025, 3:22 pm Daily Briefing May 22: Day 594 – Shock after 2 Israel embassy staffers killed in DC ...

TAL Education Group ( NYSE:TAL ) Full Year 2025 Results Key Financial Results Revenue: US$2.25b (up 51% from FY 2024... BofA lowered the firm’s price target on TAL Education (TAL) to $12.50 from ...

Verve Therapeutics has started dosing patients in a phase 1b trial of its in vivo gene-editing drug for high cholesterol, designed to permanently switch off the PCSK9 gene with a one-shot treatment.

BOSTON , May 14, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today reported pipeline updates and ...